127 related articles for article (PubMed ID: 30529062)
1. Treatment can be continued for mild cutaneous reactions associated with efavirenz.
Isaacs T; Ngwanya RM; Dlamini S; Peter J; Lehloenya R
J Allergy Clin Immunol Pract; 2019; 7(5):1676-1678. PubMed ID: 30529062
[No Abstract] [Full Text] [Related]
2. HLA-DRB1*01 associated with cutaneous hypersensitivity induced by nevirapine and efavirenz.
Vitezica ZG; Milpied B; Lonjou C; Borot N; Ledger TN; Lefebvre A; Hovnanian A
AIDS; 2008 Feb; 22(4):540-1. PubMed ID: 18301070
[TBL] [Abstract][Full Text] [Related]
3. Photodermatitis in a woman on antiretroviral therapy: report of a rare cutaneous adverse drug reaction of efavirenz and review of literature.
Mahajan VK; Gupta S; Kohli S; Rashpa RS
Int J Dermatol; 2017 Oct; 56(10):e200-e202. PubMed ID: 28626988
[No Abstract] [Full Text] [Related]
4. Two cases of successful efavirenz desensitization in patients with several anti-HIV drugs hypersensitivities.
D'Erme AM; Severino M; Tiradritti L; Testi S; Tchoimou T; Bertelli A; Zuccati G; Gola M
G Ital Dermatol Venereol; 2015 Aug; 150(4):476-8. PubMed ID: 26224235
[No Abstract] [Full Text] [Related]
5. Photosensitive drug eruption induced by efavirenz in a patient with HIV infection.
Furue M
Intern Med; 2004 Jul; 43(7):533. PubMed ID: 15335175
[No Abstract] [Full Text] [Related]
6. Is there cross-toxicity between nevirapine and efavirenz in subjects developing rash?
Soriano V; Dona C; Barreiro P; González-Lahoz J
AIDS; 2000 Jul; 14(11):1672-3. PubMed ID: 10983663
[No Abstract] [Full Text] [Related]
7. Efavirenz-induced exfoliative dermatitis.
Zhang JC; Sun YT
Scand J Infect Dis; 2013 Jan; 45(1):70-2. PubMed ID: 22715849
[TBL] [Abstract][Full Text] [Related]
8. The first case of efavirenz-induced photosensitivity in a Japanese patient with HIV infection.
Yoshimoto E; Konishi M; Takahashi K; Murakawa K; Maeda K; Mikasa K; Yamashina Y
Intern Med; 2004 Jul; 43(7):630-1. PubMed ID: 15335197
[No Abstract] [Full Text] [Related]
9. Skin eruption 8 days after a single dose of efavirenz-containing combination therapy.
Yazaki H; Kikuchi Y; Oka S
Jpn J Infect Dis; 2001 Dec; 54(6):246-7. PubMed ID: 11862010
[No Abstract] [Full Text] [Related]
10. Annular erythema and photosensitivity as manifestations of efavirenz-induced cutaneous reactions: a review of five consecutive cases.
Isaacs T; Ngwanya MR; Dlamini S; Lehloenya RJ
J Antimicrob Chemother; 2013 Dec; 68(12):2871-4. PubMed ID: 23852540
[TBL] [Abstract][Full Text] [Related]
11. Genotype-guided dose adjustment for the use of efavirenz in HIV treatment.
Lam TN; Hui KH; Chan DP; Lee SS
J Infect; 2015 Nov; 71(5):607-9. PubMed ID: 26196596
[No Abstract] [Full Text] [Related]
12. Adverse cutaneous drug reactions in patients with human immunodeficiency virus-1 infection.
Heller HM
Clin Dermatol; 2000; 18(4):485-9. PubMed ID: 11024316
[No Abstract] [Full Text] [Related]
13. Switching from efavirenz to nevirapine.
Gelinck LB; Burger DM
Clin Infect Dis; 2010 Aug; 51(3):365; author reply 365-6. PubMed ID: 20578877
[No Abstract] [Full Text] [Related]
14. Comparison of side effects with 2 doses of the HIV drug efavirenz.
Ann Intern Med; 2009 Aug; 151(3):I24. PubMed ID: 19581632
[No Abstract] [Full Text] [Related]
15. Does tenofovir increase efavirenz hepatotoxicity?
Lattuada E; Lanzafame M; Carolo G; Gottardi M; Concia E; Vento S
AIDS; 2008 May; 22(8):995. PubMed ID: 18453862
[No Abstract] [Full Text] [Related]
16. Is it safe to switch between efavirenz and nevirapine in the event of toxicity?
Mehta U; Maartens G
Lancet Infect Dis; 2007 Nov; 7(11):733-8. PubMed ID: 17961859
[TBL] [Abstract][Full Text] [Related]
17. Efavirenz: innocent bystander or direct nephrotoxin?
Wyatt CM; Rodriguez-Caprio G; Klotman PE
AIDS; 2007 Jun; 21(10):1393. PubMed ID: 17545729
[No Abstract] [Full Text] [Related]
18. The changing spectrum of the cutaneous manifestation of HIV disease.
Colebunders R; Vandenbruaene M
Arch Dermatol; 1999 Apr; 135(4):471. PubMed ID: 10206061
[No Abstract] [Full Text] [Related]
19. Photodermatitis in a patient with HIV infection.
López-Lerma I; Alsina MM; Blanco JL; Lecha M
J Am Acad Dermatol; 2003 Jul; 49(1):159-60. PubMed ID: 12833035
[No Abstract] [Full Text] [Related]
20. Efavirenz as a cause of ataxia in children.
Hauptfleisch MP; Moore DP; Rodda JL
S Afr Med J; 2015 Nov; 105(11):897-8. PubMed ID: 26632310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
